Company news
Orthocell Ltd news in 2017
Orthocell Ltd's news releases, calls and decks from 2017, newest first.
Orthocell Granted European Tendon Regeneration Patent
December 14, 2017
Ortho-ATI Case Study Publication
December 7, 2017
Orthocell Commences Treatment of Its 1,000th Patient
December 6, 2017
Orthocell Granted European Cartilage Regeneration Patent
November 30, 2017
Orthocell Receives CE Mark for CelGro
November 8, 2017
Orthocell receives R&D tax incentive refund
October 23, 2017
Orthocell Granted CelGro Patent Protection in Canada
October 15, 2017
Notice of Annual General Meeting/Proxy Form
October 13, 2017
Surgical Specialties Appointed as Exclusive Distributor
October 10, 2017
Celgro Positive Safety and Performance in Human Hip Study
September 5, 2017
1st Patient Recruited in Ortho-ATI Shoulder Tendon Study
September 4, 2017
Preliminary Final Report
August 31, 2017
Ortho-ACI on Australian Register of Therapeutic Goods
May 29, 2017
Ethics Approval Received for Pilot Ortho-ATI Tendon Study
April 30, 2017
Response to ASX Query
April 10, 2017
Singapore Patent for CelGro SMART Graft Received
March 27, 2017
Orthocell Announces Gluteal Tendon Publication
February 26, 2017
Initial Results Positive for CelGro Human Nerve Regeneration
February 21, 2017
Orthocell Submits US Regulatory Application for CelGro
February 7, 2017
Orthocell Cell Factory Patent Granted in Europe
January 30, 2017
Orthocell Announces Collaboration with Johnson & Johnson
January 11, 2017
Decks in 2017
- Investor Presentation (November 2017)
Investor deck · 34 slides · Nov 21, 2017
- Investor Presentation (October 2017)
Investor deck · 34 slides · Oct 17, 2017
- Investor Presentation (February 2017)
Investor deck · 31 slides · Feb 27, 2017